Factors associated with the no-reflow phenomenon following percutaneous intervention of saphenous vein coronary bypass grafts

سال انتشار: 1396
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 151

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_RYA-13-5_004

تاریخ نمایه سازی: 2 شهریور 1401

چکیده مقاله:

BACKGROUND: We investigated clinical and procedural factors associated with the no-reflow phenomenon following percutaneous coronary intervention (PCI) of the saphenous-vein grafts (SVG). METHODS: A cross-sectional study was done on patients who had undergone PCI of the SVG. Patients’ medical documents were reviewed for demographic, clinical, laboratory, and procedural data. Slow/no-reflow was defined based on the thrombolysis in myocardial infarction (TIMI) grade (۰ to ۲). Univariate and multiple logistic regression analyses were performed to investigate factors associated with slow/no-reflow and P < ۰.۰۵۰ was considered as significant. RESULTS: A total of ۲۰۵ patients were studied (۸۱% man, mean ± standard deviation of age was ۶۶.۸ ± ۹.۶ years). Slow/no-reflow was found in ۳۸ (۱۸.۵%) patients. High diastolic blood pressure (P = ۰.۰۱۰), leukocytosis (P = ۰.۰۱۷), diffuse lesions (P = ۰.۰۰۷), degenerated SVG (P < ۰.۰۰۱), proximal lesions (P < ۰.۰۰۱), thrombosis (P = ۰.۰۱۳), and lower number of used stents during procedure (P = ۰.۰۳۲) were associated with slow/no-reflow in unadjusted analyses. Factors independently associated with slow/no-reflow were pre-procedural high diastolic blood pressure with odds ratio (OR) = ۳.۸۵۸ [۹۵% confidence interval (۹۵% CI), ۱.۱۵۷-۱۲.۸۶۰], degenerated SVG with OR = ۵.۹۰۱ (۹۵% CI: ۱.۸۸۳-۱۸.۴۹۲), proximal lesions with OR = ۵.۰۷۰ (۹۵% CI: ۱.۸۲۲-۱۴.۱۱۳), pre-intervention TIMI grade with OR = ۰.۶۱۸ (۹۵% CI: ۰.۴۰۵-۰.۹۴۲), number of used stents for PCI with OR = ۰.۰۷۴ (۹۵% CI: ۰.۰۱۱-۰.۴۸۱) for > ۱ stent, and length of stents used for PCI with OR = ۰.۱۰۰ (۹۵% CI: ۰.۰۱۹-۰.۵۲۹) for > ۳۰ mm stents. CONCLUSION: This study on the clinical and procedural factors associated with the slow/no-reflow phenomenon following PCI of the SVG can be used in risk estimation of this serious complication and tailoring preventive strategies to at-risk patients.   

نویسندگان

Mohammad Hashemi-Jazi

Professor, Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Sayed Mojtaba Hosseini

Professor, Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Ali Gholamrezaei

General Practitioner, Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, ...
  • Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C. ...
  • Harskamp RE, Lopes RD, Baisden CE, de Winter RJ, Alexander ...
  • Soverow J, Lee MS. Saphenous vein graft intervention: Status report ...
  • Eid-Lidt G, Gaspar J, Adames AE, Damas de Los SF, ...
  • Eeckhout E, Kern MJ. The coronary no-reflow phenomenon: A review ...
  • Jaffe R, Charron T, Puley G, Dick A, Strauss BH. ...
  • Niccoli G, Kharbanda RK, Crea F, Banning AP. No-reflow: Again ...
  • Hong YJ, Jeong MH, Ahn Y, Kang JC, Mintz GS, ...
  • Sdringola S, Assali AR, Ghani M, Moustapha A, Achour H, ...
  • Liu MW, Douglas JS Jr, Lembo NJ, King SB ۳rd. ...
  • Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF ...
  • Eeckhout E. Percutaneous Interventional Cardiovascular Medicine: The PCR-EAPCI Textbook. London, ...
  • The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. ...
  • Morishima I, Sone T, Mokuno S, Taga S, Shimauchi A, ...
  • Harrison RW, Aggarwal A, Ou FS, Klein LW, Rumsfeld JS, ...
  • Zhou H, He XY, Zhuang SW, Wang J, Lai Y, ...
  • Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, ...
  • Dong-bao L, Qi H, Zhi L, Shan W, Wei-ying J. ...
  • Dobrzycki S, Kozuch M, Kaminski K, Korecki J, Ostasz A, ...
  • Iwakura K, Ito H, Kawano S, Okamura A, Kurotobi T, ...
  • Hu T, Wang HC, Wang RT, Lv AL, Luan RH, ...
  • Shemirani H, Tafti FD, Amirpour A. Comparison of no-reflow phenomenon ...
  • Turkmen S, Dogdu O, Tekin K, Kucukdurmaz Z, Cagliyan CE, ...
  • Engler RL, Schmid-Schonbein GW, Pavelec RS. Leukocyte capillary plugging in ...
  • Brosh D, Assali AR, Mager A, Porter A, Hasdai D, ...
  • Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S, ...
  • Akpek M, Kaya MG, Lam YY, Sahin O, Elcik D, ...
  • Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation ۲۰۰۲; ۱۰۵(۵): ۶۵۶-۶۲ ...
  • Botto N, Sbrana S, Trianni G, Andreassi MG, Ravani M, ...
  • Jinnouchi H, Sakakura K, Wada H, Arao K, Kubo N, ...
  • Kurtul A, Murat SN, Yarlioglues M, Duran M, Celik IE, ...
  • Yilmaz MB, Yalta K. Coronary flow slows as renal function ...
  • Hong YJ, Jeong MH, Choi YH, Ko JS, Lee MG, ...
  • Jiao Q, Ke Q, Li W, Jin M, Luo Y, ...
  • Ndrepepa G, Tiroch K, Keta D, Fusaro M, Seyfarth M, ...
  • Orn S, Manhenke C, Ueland T, Damas JK, Mollnes TE, ...
  • Hong YJ, Jeong MH, Choi YH, Ko JS, Lee MG, ...
  • Antoniucci D, Valenti R, Migliorini A, Moschi G, Bolognese L, ...
  • Li C, Zhang B, Li M, Liu J, Wang L, ...
  • Leborgne L, Cheneau E, Waksman R. Randomized trial of a ...
  • Cohen DJ, Murphy SA, Baim DS, Lavelle TA, Berezin RH, ...
  • نمایش کامل مراجع